Target intelligence / Profile preview

Voltage-dependent T-type calcium channel subunit alpha-1H (CACNA1H)

Target
CACNA1H
Molecular classification
Ion channel, Calcium channel
01

Overview

Voltage-dependent T-type calcium channel subunit alpha-1H, encoded by the CACNA1H gene and commonly known as Cav3.2, is a low-voltage-activated calcium channel that plays a critical role in regulating neuronal excitability, rhythmic pacemaking, and calcium homeostasis. It is widely expressed in the central nervous system, particularly in the thalamus and sensory neurons of the dorsal root ganglia, as well as in peripheral tissues such as the adrenal gland and heart. In the brain, Cav3.2 contributes to burst firing patterns and thalamocortical oscillations, while in the adrenal cortex, it participates in the signaling pathway that triggers aldosterone production. Mutations and dysregulation of Cav3.2 are strongly implicated in childhood absence epilepsy, neuropathic pain, essential tremor, and primary aldosteronism. Consequently, Cav3.2 is a major therapeutic target for the development of anticonvulsants, analgesics, and antihypertensive agents. Pharmacological agents targeting this channel include selective blockers like ulixacaltamide and ACT-709478, as well as broader T-type calcium channel inhibitors like mibefradil and ethosuximide, which aim to suppress pathological hyper-excitability and abnormal hormone secretion.

Other names
Calcium voltage-gated channel subunit alpha1 HCav3.2Low-voltage-activated calcium channel alpha1 3.2 subunitCACNA1HBECA6EIG6HALD4
02

Mechanism of action

T-type calcium channel blockade / antagonism

03

Biological functions

Calcium ion transportRegulation of membrane potentialNeuronal excitabilityRhythmic firingPacemakingAldosterone secretion
04

Disease associations

EpilepsyNeuropathic painPrimary aldosteronismEssential tremorHypertension
05

Safety considerations

SedationDizzinessAtaxiaCardiovascular effectsEndocrine disruption
06

Interacting drugs

11 more in the full profile.

07

Biomarkers

CACNA1H gene mutationsAldosterone-to-renin ratioCYP11B2 expression

Beyond the preview

Go deeper on Voltage-dependent T-type calcium channel subunit alpha-1H (CACNA1H).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent T-type calcium channel subunit alpha-1H (CACNA1H).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call